Small-molecule inhibitor shows potential for diffuse large B-cell lymphoma therapy

被引：0
|
作者：
不详
机构：
来源：
EXPERT REVIEW OF HEMATOLOGY | 2010年 / 3卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：524 / 524
页数：1
相关论文
共 50 条
  • [31] AKT Hyperactivation and the Potential of AKT-Targeted Therapy in Diffuse Large B-Cell Lymphoma
    Wang, Jinfen
    Xu-Monette, Zijun Y.
    Jabbar, Kausar J.
    Shen, Qi
    Manyam, Ganiraju C.
    Tzankov, Alexandar
    Visco, Carlo
    Wang, Jing
    Montes-Moreno, Santiago
    Dybkaer, Karen
    Tam, Wayne
    Bhagat, Govind
    Hsi, Eric D.
    van Krieken, J. Han
    Ponzoni, Maurilio
    Ferreri, Andres J. M.
    Wang, Shi
    Moller, Michael B.
    Piris, Miguel A.
    Medeiros, L. Jeffrey
    Li, Yong
    Pham, Lan V.
    Young, Ken H.
    AMERICAN JOURNAL OF PATHOLOGY, 2017, 187 (08): : 1700 - 1716
  • [32] The potential of antibody-drug conjugates for effective therapy in diffuse large B-cell lymphoma
    Ahmed, Gulrayz
    Hamadani, Mehdi
    Al-Juhaishi, Taha
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2025, 25 (02) : 161 - 173
  • [33] Diffuse Large B-cell Lymphoma in the Elderly: A Review of Potential Difficulties
    Sarkozy, Clementine
    Coiffier, Bertrand
    CLINICAL CANCER RESEARCH, 2013, 19 (07) : 1660 - 1669
  • [34] The potential of serum light chains in diffuse large B-cell lymphoma
    Maurer, Matthew J.
    LEUKEMIA & LYMPHOMA, 2013, 54 (09) : 1857 - 1858
  • [35] The potential role of glycogen metabolism in diffuse large B-cell lymphoma
    Jalali, Shahrzad
    Ansell, Stephen M.
    LEUKEMIA & LYMPHOMA, 2020, 61 (05) : 1028 - 1036
  • [36] Biomarkers of potential prognostic significance in diffuse large B-cell lymphoma
    Wu, G
    Keating, A
    CANCER, 2006, 106 (02) : 247 - 257
  • [37] Potential prognostic and predictive factors in diffuse large B-cell lymphoma
    Flodr, P.
    Latalova, P.
    Tichy, M.
    Kubova, Z.
    Papajik, T.
    Svachova, M.
    Radova, L.
    Jarosova, M.
    VIRCHOWS ARCHIV, 2014, 465 : S277 - S277
  • [38] Enzastaurin, an oral protein kinase CP inhibitor with potential activity in diffuse large B-cell lymphoma
    Reddy, GK
    CLINICAL LYMPHOMA & MYELOMA, 2006, 6 (04): : 265 - 267
  • [39] Diffuse Large B-cell lymphoma: Prognostic markers and their impact on therapy
    Jamil, Muhammad O.
    Mehta, Amitkumar
    EXPERT REVIEW OF HEMATOLOGY, 2016, 9 (05) : 471 - 477
  • [40] De-Cell-eration in Therapy for Diffuse Large B-Cell Lymphoma
    Leonard, John P.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15) : 1267 - +
12345